Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide treatment attenuates social defeat-induced anxiety in rats
- 1 October 1994
- journal article
- contemporary techniques
- Published by Springer Science and Business Media LLC in Cellular and Molecular Neurobiology
- Vol. 14 (5), 579-588
- https://doi.org/10.1007/bf02088839
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The Role of Corticotropin‐Releasing Factor in Behavioural Responses to StressPublished by Wiley ,2007
- Antisense oligodeoxynucleotide complementary to oxytocin mRNA blocks lactation in ratsExperimental and Clinical Endocrinology & Diabetes, 1995
- Antisense Oligodeoxynucleotides for In Vivo Targeting of Corticotropin-Releasing Hormone mRNA: Comparison of Phosphorothioate and 3′-Inverted Probe PerformanceHormone and Metabolic Research, 1994
- Vasopressin Antisense Oligonucleotide Induces Temporary Diabetes Insipidus in RatsJournal of Neuroendocrinology, 1994
- Modulation of Anxiety and Neuropeptide Y-Y1 Receptors by Antisense OligodeoxynucleotidesScience, 1993
- Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?Brain Research Reviews, 1990
- Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: A hybridization histochemical study in the ratJournal of Comparative Neurology, 1989
- Animal models for the study of anti-anxiety agents: A reviewNeuroscience & Biobehavioral Reviews, 1985
- Organization of Ovine Corticotropin-Releasing Factor Immunoreactive Cells and Fibers in the Rat Brain: An Immunohistochemical StudyNeuroendocrinology, 1983
- Intraventricular corticotropin-releasing factor enhances behavioral effects of noveltyLife Sciences, 1982